Unless Quantum reports backlogs differently. Backlog is the tracking of orders from quarter to quarter. It looks like the number of orders for tanks was significantly lower compared to the third quarter. Maybe it is seasonal, but it is something that I would question. I plan to listen to the conference call or read the transcript tonight to see if this is addressed.
Can anyone address the drop in the backlog noted between the 3rd and 4th quarter results:
CNG gross revenue went frm $6.7M to $8.0M; however, the Backlog dropped off the roof from $18.7M in the 3rd quarter down to $13.0M at the end of the 4th quarter. To me this shows that orders expansion dropped considerably.
10 hours ago you were asking the impact on the price for this dilution. I guess you were standing in the stupid crowd for a little bit.
Got lucky and unloaded my shares pre-market at $7.66. I expect this to trade down to $6.50 today. I might buy back in!
Please note that this is a "article" not a MD Anderson study. I doubt PVCT will release a press release on this article. They may point or post it to the web site.
You should really provide more context: The combinatory approach was never part of the clinical trail and was only identified after PV-10 treatment in 3 patients. For those who don't have a copy of the article.
No... NO.. product sales last quarter. Nearly $7M in R&D and same in SG&A and no... NO product sales. The only thing you can say is they have an infinite margin.
What a joke.
"As advised by the Agency, we will submit data from the 28 patients in our Phase 2 study who had all existing disease treated in a formal BTD request this quarter, and should receive a decision within 60 days of receipt of that request.”
You really need to do you some research on the purpose and conduct of FDA Meeting be they type A, B, C or others. Google 21CFR312.47 and 21CFR10.65 and read. You will note that the meeting outcome are simply agreements (FDA direction) between the applicant and the FDA. If you review other Type C meeting responses you will see that in most cases an agreed upon roadmap is established. The meeting minutes are taken and issue by the FDA not the applicant. Then go back and read the PR in this light. The FDA was aware of the limited number of treated individuals yet agreed to PVCT submission of an BTD.
You can also obtain a copy of these minutes by requesting them via the FOIA directly to the FDA. If more then three people make the request the FDA will usually post the meeting minutes on their website.
Go to Google Books and do a search on "Rose Bengal Disodium PV-10". Select the first book "Cytokines - Advances in Research and Application - 2013 Edition". It should take you to page 254. Read the next three pages for information on PV-10. Enjoy
I am sure that Peter was advised to not talk to Mr. Feuerstein especially after reviewing his posts. Someone likely called Adam and told him nicely that the meeting was cancelled and will not be rescheduled. What's the point to in talking to such a negative person? There is no benefit. Leave the conversions to God.
My fault. I am almost done with my review. I will get it back my input back tomorrow and it should be out after the close.
I was just attempting to add some comic relief to the message board. I sorry it is offended. I try not to label people with cancer since I believe that we all have pre-cancerous cells in our body. It is when the body becomes out of balance and unable to maintain a natural control of these cells that we say a person has "cancer". That is why I am both an investor and believer in PV-10 and other immune boosting drugs. Doctors and the drugs they prescribe should help the body's amazing healing processes to recognize and attempt to regain a natural balance. Today most of the drugs (as pointed out in my comical post) attack and destroys more than just the cancer. They destroy the ability for the body to healing. That is why the fight against cancer goes on and on.
I think Big Pharma will have a horrible time developing a commercial for PV-10. What will they say to fill the time? Only minor local (at the injection site) irritation? Give me a break. No one will believe this drug works. All the other drug commercials can at least proclaim "Consult your doctor if you have uncontrollable rectal bleeding, trouble breathing, violent diarrhea, or premature death".
You are aware that PV-10 has already been proven to extent patient's lives?
The final efficacy data on PV-10, presented at the ESMO meeting in Vienna, Austria, demonstrated a significant robust response rate (60% OR, and 79% disease control) in Stage III subjects. This group also achieved significantly greater mean progression free survival of at least 9.7 months, versus later stage subjects.
Anyone out there willing to help Provectus set up a professionally looking website? I understand they have only four employee and obviously they have limited web development skills. Any volunteers?